A biochemical analysis of the constraints of tail-anchored protein biogenesis by Leznicki, Pawel et al.
Biochem. J. (2011) 436, 719–727 (Printed in Great Britain) doi:10.1042/BJ20101737 719
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TA(tail-anchored)proteinsutilizedistinctbiosyntheticpathways,
including TRC40 (transmembrane domain recognition complex
of 40 kDa)-mediated, chaperone-dependent and/or unassisted
routes to the ER (endoplasmic reticulum) membrane. We have
addressed the ﬂexibility of cytosolic components participating
in these pathways, and explored the thermodynamic constraints
of their membrane insertion, by exploiting recombinant forms of
Sec61β and Cytb5 (cytochrome b5) bearing covalent modiﬁ-
cations within their TA region. In both cases, efﬁcient membrane
insertion relied on cytosolic factors capable of accommodating
a surprising range of covalent modiﬁcations to the TA region.
For Sec61β, we found that both SGTA (small glutamine-
rich tetratricopeptide repeat-containing protein α) and TRC40
can bind this substrate with a singly PEGylated TA region.
However, by introducing two PEG [poly(ethylene glycol)]
moieties, TRC40 binding can be prevented, resulting in a block
of subsequent membrane integration. Although TRC40 can bind
Sec61β polypeptides singly PEGylated at different locations,
membrane insertion is more sensitive to the precise location
of PEG attachment. Modelling and experimentation indicate
that this post-TRC40 effect results from an increased energetic
cost of inserting different PEGylated TA regions into the lipid
bilayer. We therefore propose that the membrane integration of
TA proteins delivered via TRC40 is strongly dependent upon
underlying thermodynamics, and speculate that their insertion is
via a phospholipid-mediated process.
Key words: cytochrome b5(Cytb5), PEGylation, Sec61β, small
glutamine-rich tetratricopeptide repeat-containing protein α
(SGTA), tail-anchored protein (TA protein), transmembrane
domain recognition complex of 40 kDa (TRC40).
INTRODUCTION
TA (tail-anchored) proteins constitute a group of integral
membrane proteins characterized by the presence of a single
C-terminally localized stretch of hydrophobic amino acids that
acts as both the subcellular targeting signal andmembrane anchor
[1].AlthoughTAproteinsarefoundinmost,ifnotall,intracellular
membranes, the ER (endoplasmic reticulum) acts as the entry
site for TA proteins destined for the various compartments of
the secretory pathway [2–5]. Importantly, the C-terminal location
of the membrane-spanning region precludes its co-translational
recognition by the SRP (signal recognition particle), ensuring
that TA protein targeting to, and insertion into, the ER membrane
is post-translational [4].
The precise route of TA protein delivery to the ER
membrane is precursor-dependent and correlates with the relative
hydrophobicity of the TMS (transmembrane segment) of the
tail-anchor region [6–8]. Thus, comparatively hydrophilic tail
anchors, such as those of Cytb5 (cytochrome b5) and protein
tyrosinephospatase1B,deﬁneapathway(s)thatiseithermediated
by Hsp70 (heat-shock protein 70)/Hsp40 chaperones [8,9] and/or
does not utilize any cytosolic components [10]. This pathway(s)
does not rely on a speciﬁc receptor at the ER membrane; hence
protease-treated microsomes are still fully capable of accepting
the TA protein substrate [6,11].
The majority of TA proteins, such as RAMP4 (ribosome-
associated membrane protein 4) and Sec61β,h a v eaT Ar e g i o n
predicted to be more hydrophobic than that of Cytb5 [12]. These
precursors use a specialized targeting factor, known as TRC40
(transmembrane domain recognition complex of 40 kDa; Asna1)
in mammalian cells [13,14] and Get3 (guided entry of tail-
anchored proteins 3) in Saccharomyces cerevisiae [15,16], for
their delivery to the ER membrane. The TRC40/Get3 pathway
requires additional cytosolic factors, such as Get4/Get5 and
Sgt2 in yeast [17–20], and a membrane-bound receptor that
has been deﬁned as the Get1–Get2 complex in S. cerevisiae
[16]. Recent structural analyses of the Get3 protein [21–25]
and associated components [26,27] have provided new insights
into the relationship between its ATPase cycle and TA protein
delivery to the ER membrane and identiﬁed the likely substrate-
binding site. However, since none of the current Get3 structures
were obtained as a complex with a TA protein substrate, several
aspects of substrate recognition by Get3 remain to be elucidated.
Moreover, the precise details of TA protein recognition by
upstreamcomponents,suchasSgt2anditsmammalianequivalent
SGTA (small glutamine-rich tetratricopeptide repeat-containing
protein α), are also currently unclear (see [20,28]).
To date, many biochemical studies addressing the biogenesis
of TA proteins at the ER membrane have relied upon substrates
generated by in vitro translation using cell lysates that contain
essential cytosolic factors (see [7]). However, a bacterial system
has recently been exploited to co-express model TA proteins with
TRC40/Get3 [21,29], and the resulting complexes were shown
to be sufﬁcient for facilitating membrane insertion, indicating
that TRC40/Get3 acts at a very late stage of TA protein delivery
to the ER. Studies using puriﬁed recombinant TA proteins
expressed in the absence of known cytosolic interacting partners
are limited, and have largely focused on Cytb5 [10,30]. The use
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of recombinant TA proteins allows polypeptide synthesis to be
physically and temporally separated from the ER delivery and
membrane insertion steps, facilitating studies of the components
involved in these processes. Indeed, we have recently taken
this approach to study Sec61β biogenesis, and identiﬁed a
novel role for Bat3 during TRC40-dependent ER delivery [28].
Notwithstanding the potential advantages of using recombinant
forms of TA proteins [31], this approach has not been exploited
extensively to date.
In the present study, we describe the successful production
of recombinant TA protein models for each of the two major
biosyntheticpathways,namelySec61β andCytb5.Bychemically
modifying these recombinant TA protein substrates, we show that
both routes are surprisingly unconstrained, and can accommodate
substrates with signiﬁcantly modiﬁed transmembrane domains.
Remarkably, PEGylated forms of both Sec61β and Cytb5 can
also be efﬁciently integrated into the ER membrane, albeit via
different routes. We ﬁnd that the cytosolic factors SGTA and
TRC40 can both accommodate substrates with a PEGylated
TA region, and provide a model for the ER delivery and
membrane integration of PEGylated Sec61β. By analysing
additional variants of Sec61β, we show that the location of the
PEG[poly(ethyleneglycol)]moietywithintheTAregionstrongly
inﬂuences membrane integration in a manner that correlates with
the predicted thermodynamic cost of this process. On this basis,
we speculate that the membrane insertion step of the TRC40-
dependent pathway for TA protein biogenesis may be a purely
lipid-mediated event that does not require a dedicated integrase.
EXPERIMENTAL
Materials
Bacterial expression vector pHisTrx was a gift from Richard
Kammerer (Paul Scherrer Institute, Villigen, Switzerland).
Rabbit polyclonal antiserum recognizing TRC40 was a gift
from Bernhard Dobberstein [ZMBH (Zentrum f¨ ur Molekulare
Biologie der Universit¨ at Heidelberg), Heidelberg, Germany]. All
detergents were from Anatrace, except Triton X-100, which
was from Sigma. Cross-linking reagents and EZ-link-biotin
were from Pierce, whereas BODIPY® [boron dipyrromethene
(4,4-diﬂuoro-4-bora-3a,4a-diaza-s-indacene)] and IASD {4-
acetamido-4
 -[(iodoacetyl)amino]stilbene-2,2
 -disulfonate} were
from Molecular Probes. mPEG [methoxypoly(ethylene glycol)]-
5000 and mPEG-20000 maleimides were from Nektar. Nuclease-
treated rabbit reticulocyte lysate was supplied by Promega.
Chemical modiﬁcation of recombinant TA proteins
Recombinant TA proteins were expressed and puriﬁed
as described previously [28], with the various cysteine
residue mutants generated by site-directed mutagenesis and
conﬁrmed by DNA sequencing. Thiol-reactive probes, as
indicated, were mixed with solutions of single cysteine
residue mutants of Sec61βOPG
S77C (where OPG is opsin
glycosylation tag) (77 μM) in buffer B [50 mM Tris/HCl,
pH 7.4, 300 mM NaCl, 10 mM imidazole, 10% (v/v)
glycerol, 0.75% (w/v) OG (octyl β-D-glucopyranoside)] and
Cytb5OPG
S119C (25 μM) in buffer Q [50 mM Hepes/KOH,
pH 7.9, 50 mM potassium acetate, 200 mM NaCl, 10% (v/v)
glycerol, 0.1% LDAO (dodecanoyldimethylamine-N-oxide)]
(see Supplementary Table S1 at http://www.BiochemJ.org/
bj/436/bj4360719add.htm for details of the mutants) using the
reagentsataﬁnalconcentrationof1–3 mMandincubatingfor2 h
atroomtemperature(21◦C)inthedark.Reactionswerequenched
by addition of 20 mM 2-mercaptoethanol and further incubation
for 10 min. Modiﬁed proteins were resolved by SDS/PAGE and
then stained with Coomassie Brilliant Blue or immunoblotted
with the anti-opsin tag antibody, or they were used for membrane
integration reactions. All other Sec61βOPG cysteine mutants
(see Supplementary Table S1) were puriﬁed and labelled as
described using 1.5 mM mPEG-5000 maleimide, pre-quenched
with glycine, for 1 h at 25◦C. After quenching any unchanged
maleimides, labelled proteins were analysed as above or used for
integration assays. Membrane integration assays of recombinant
TA proteins were performed using sheep pancreatic microsomes
as described previously [28].
Binding of PEGylated Sec61βOPG to recombinant SGTA and
endogenous TRC40
Human SGTA was expressed in Escherichia coli BL21 Gold
(DE3) pLysS cells and puriﬁed essentially as described above
for TA proteins. HisTrx (histidine–thioredoxin)–SGTA, or BSA
control, was then immobilized on UltraLink Biosupport beads
(ThermoScientiﬁc) according to the manufacturer’s instructions.
Recombinant PEGylated Sec61βOPG variants were mixed with
beadsin buffer S [50 mM Hepes/KOH, pH 7.5,40 mM potassium
acetate, 5 mM MgCl2 and 0.05% pMAL-C12 amphiphile
(Anatrace)],togiveaﬁnalconcentrationof3.3 μMandincubated
for 1 h at 4◦C. Beads were washed with buffer S plus 0.5 M NaCl
and any bound material eluted ﬁrst with buffer S supplemented
with 0.5% (v/v) Triton X-100, and then mixed with Laemmli
sample buffer.
Association of PEGylated Sec61βOPG variants with
endogenous TRC40 was tested by incubating 1–1.9 μMo f
recombinant modiﬁed Sec61βOPG with 140 μl of rabbit
reticulocyte lysate for 30 min at 30◦C. Reaction mixtures
were then split into two and each half was added to 20 μl
[50% (v/v) suspension] of Protein A–Sepharose coated with
7.5 μl of rabbit anti-TRC40 or anti-PDI (protein disulﬁde-
isomerase) antisera. The lysate was incubated with anti-Protein
A–Sepharose antibody beads for 1 h at 4◦C, the resin was then
washed extensively with buffer R (50 mM Hepes/KOH, pH 7.5,
40 mM potassium acetate and 5 mM MgCl2) supplemented with
0.5 M NaCl, and bound proteins were eluted with buffer R
containing 0.5% (v/v) Triton X-100 (cf. [13]). The eluate
was mixed with Laemmli sample buffer, and samples were
resolved on SDS/PAGE and immunoblotted with the anti-opsin
tag antibody. Quantitative analysis was carried out using a LiCor
Biosciences system (described below). The non-speciﬁc binding
of the indicated Sec61βOPG variants to anti-PDI antibody-
coated Protein A–Sepharose beads was subtracted from the
results obtained using anti-TRC40 antibody-coated Protein A–
Sepharose,andtheresultingvalueswerenormalizedtotheamount
of each Sec61βOPG species present in the starting material (see
Supplementary Figure S1 for a full worked example).
Quantitative immunoblotting
Following transfer of the samples on to a low-ﬂuor PVDF
membrane and incubation with a primary anti-opsin epitope
tag antibody, a secondary anti-mouse ﬂuorescent-dye-conjugated
antibody was added at 1:10000 dilution. The membrane was
incubated for 1 h at room temperature, scanned using a LiCor
Biosciences system and the results were quantiﬁed with Odyssey
2.1 software.
Protease protection of membrane-integrated Sec61βOPG variants
Two membrane integration reaction mixtures were combined.
Microsomes were isolated as described previously [28] and
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Figure 1 Chemically modiﬁed TA proteins are integrated into ER-derived membranes
Sec61βOPGS77C (A) and Cytb5OPG (C) with single cysteine residues located in their TMSs (see Supplementary Table S1 at http://www.BiochemJ.org/bj/436/bj4360719add.htm) were modiﬁed
(modif.) with thiol-reactive probes or the homobifunctional crosslinking reagent BMH, as indicated, and the products were analysed by immunoblotting. Full-length Sec61βOPG (>), a truncated
form () and cross-linked dimers () are indicated, as are the monomer and dimer of Cytb5OPG (1xb5 and 2xb5 respectively). PEG-5000- and PEG-20000-modiﬁed Sec61βOPG ( and 
respectively),andPEGylatedCytb5OPGmonomer()anddimer()areindicated.Otherproductsassumedtorepresentabberantcross-linkedspecies(?and)werenotcompetentformembrane
integration (integr.) and their precise identity was not pursued. (B and D) N-glycosylated species are indicated with an asterisk (*), except the N-glycosylated, PEG-modiﬁed Cytb5OPG dimer ( )
(D, lane 7). A product corresponding to the PEGylated Cytb5OPG dimer, and an N-glycosylated, non-PEGylated dimer that co-migrate is also indicated (∞). Molecular mass markers in kDa are also
indicated on the right-hand side of the Western blots.
resuspended in 68 μl of LSS (low-salt sucrose) buffer [250 mM
sucrose, 100 mM potassium acetate, 5 mM magnesium acetate
and 50 mM Hepes/KOH, pH 7.9]. The suspension was then split
into three and each 20 μl aliquot received 2 μl of water, 2 μlo f
proteinase K (2.5 mg/ml) or 2 μl of proteinase K (2.5 mg/ml) and
2.2 μlo f1 0% (v/v) Triton X-100. Digestion was carried out on
ice for 30 min and proteinase K was inhibited by the addition of
2.5 mM PMSF and further incubation on ice for 10 min. Laemmli
buffer was then added and the samples were immediately heated
to 95◦C for 10 min. Samples were resolved on a 16% (v/v)
Tris/Tricinepolyacrylamidegelandimmunoblottedwiththeanti-
opsin epitope tag antibody.
RESULTS
Recombinant TA proteins are inserted into the ER membrane
Preliminary analysis indicated that a HisTrx-based fusion was
superior to a glutathione transferase tag for the high-level
expression and puriﬁcation of the recombinant TA proteins
used in the present study (results not shown). We used this
approach to purify and characterize two model recombinant TA
proteins, Sec61β and Cytb5, each of which favours a distinct
pathway for their biogenesis at the ER membrane (see the
Introduction; also [7,8,13,14,32]). Cells expressing recombinant
TA proteins were lysed in the presence of detergent, soluble
fractions were incubated with Ni-NTA (Ni
2+-nitrilotriacetate)–
agarose and, after washing the beads with buffer containing a low
concentration of detergent, the various proteins were released
from the tag by thrombin-mediated cleavage ([10,28,30]; see
also the Experimental section and Supplementary Table S1).
Coomassie Blue staining showed an acceptable level of protein
purity, with only a fraction of Sec61βOPG and Cytb5OPG
present in truncated forms (see Supplementary Figure S2A at
http://www.BiochemJ.org/bj/436/bj4360719add.htm).
Themembraneintegrationcapacityoftherecombinantproteins
was investigated using a well-established N-glycosylation assay
that relies on a short C-terminal opsin-derived epitope tag
[4,8,11,13,33]. Crucially, this modiﬁcation can only take place
when the protein spans the membrane and the tag has entered
the ER lumen, consistent with authentic membrane integration.
Substantial levels of EndoH (endoglycosidase H)-sensitive
protein species for both Sec61βOPG and Cytb5OPG were
observed (Supplementary Figure S2B, cf. lanes 1 and 2, 3 and
4), clearly indicating that these two precursors are efﬁciently
integrated into the ER membrane in the presence of cytosol.
Chemically modiﬁed TA proteins are efﬁciently inserted into the ER
membrane
Puriﬁed Sec61βOPG and Cytb5OPG, both bearing single
cysteine residues within their TA regions (Sec61βOPG
S77C and
Cytb5OPG
S119C; see Supplementary Table S1), were treated
with a variety of thiol-reactive probes differing in size and
physicochemical properties (Figures 1A and 1C). In the case
of PEGylation, the modiﬁcation was conﬁrmed by a shift in
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electrophoretic mobility (see Figures 1A and 1C), whereas for
BODIPY®, the ﬂuorescently tagged protein could be visualized
after membrane integration (see Supplementary Figure S3 at
http://www.BiochemJ.org/bj/436/bj4360719add.htm).Inthecase
of IASD and biotinylation, we have not directly conﬁrmed
labelling, and cannot rule out the possibility that little if any
protein was modiﬁed. However, the biotinylation reagent also
generated covalently linked dimers of Sec61βOPG, most likely
resulting from trace amounts of bifunctional cross-linkers present
in the commercial reagent (Figure 1A, lane 2, •). This conclusion
is strongly supported by the fact that we can generate apparently
identical species upon treatment with a bifunctional maleimide
(Figure 1A, lane 7, •). Treatment with mPEG-5000 maleimide
and BMH [bis(maleimido)hexane] also generated even larger
species (Figure 1A, lanes 5 and 7, ? and  respectively), but since
these derivatives were not recovered in the membrane fraction
after further analysis (cf. Figure 1B, lanes 9 and 10, 13 and 14),
they were not further characterized. In the case of Cytb5OPG, a
small amount of SDS-stable dimer was observed in the absence
of any additional treatment (Figure 1C, lane 1). A similar species
became more prominent after incubation with both mPEG-5000
maleimideandBMH,presumablyduetocovalentcross-linkingof
the dimer (Figure 1C). Both the monomeric and dimeric forms of
Cytb5OPGappearedtobemodiﬁedwithmPEG-5000(Figure1C,
lane 2,  and  respectively). Additional high-molecular-mass
species were also observed with BMH (Figure 1C, lane 3, ),
but as for Sec61βOPG, little if any of these unassigned species
were recovered in association with ER-derived membranes (cf.
Figure 1D). Hence our analysis showed that cysteine residues
introduced into the TA regions of both recombinant proteins can
becovalentlymodiﬁedbyPEGylationandcross-linkingreagents,
whereas Sec61βOPG can also accept a number of other thiol-
reactive probes.
A role for cytosolic components during the membrane
integration of Cytb5 is controversial [7,8,10]. Our previous
analysis of recombinant Cytb5OPG found that immunodepletion
of TRC40 or Bat3 from cytosol had no effect on its insertion,
clearly distinguishing its integration from that of Sec61βOPG
[28]. This difference is further underlined when the kinetics of
membraneinsertionforrecombinantCytb5OPGandSec61βOPG
are compared (see Supplementary Figures S2C and S2D), with
Cytb5OPG integration reaching completion substantially more
rapidly(cf.[34]).Wethereforeestablishedwhetherthemembrane
integration of recombinant Cytb5OPG is cytosol-dependent in
our assay. We can only detect the N-glycosylation of Cytb5OPG
in the presence of both cytosol and ER-derived membranes
(Figure 1D, lanes 1 to 4), using experimental conditions where
the efﬁcient N-glycosylation of recombinant TA proteins has
been observed in the presence of buffer alone [21,29]. We
therefore conclude that the efﬁcient membrane integration of
the recombinant Cytb5OPG used in our experimental system is
cytosol-dependent.
Toexaminetheconstraintsonthecellularcomponentsinvolved
in the biogenesis of Sec61βOPG and Cytb5OPG, we tested the
cytosol-dependent integration of the two modiﬁed recombinant
polypeptides into ER-derived membranes. Remarkably, none of
the treatments with thiol-reactive reagents tested resulted in a
complete block of membrane integration, despite the location of
the target cysteine residue within the TA region of both proteins
(Figure 1B, lanes 1–12 and Figure 1D, cf. lanes 3 and 4, 7 and
8). In fact, even homodimers of both Sec61βOPG and Cytb5OPG
were still measurably inserted into the lipid bilayer (Figure 1B,
cf. lanes 3, 4, 13 and 14 and Figure 1D, cf. lanes 3, 4, 11
and 12). Membrane integration of a Cytb5OPG dimer occurred
both with and without prior BMH treatment, suggesting that the
close proximity of the two TA regions of the protein monomers
does not preclude membrane integration of a Cytb5OPG dimer
(Figure 1D, cf. lanes 3 and 4, 11 and 12). A more detailed
analysis of Sec61βOPG dimers, generated by using cross-linking
reagents of different length spacers, revealed that membrane
integration was not qualitatively affected by the distance
between individual subunits (see Supplementary Figure S4A at
http://www.BiochemJ.org/bj/436/bj4360719add.htm). Moreover,
partial EndoH digestion of the membrane-associated material
showed that both subunits of Sec61βOPG and Cytb5OPG dimers
are N-glycosylated, indicating that both polypeptides are fully
inserted into the ER membrane (Supplementary Figures S4B
and S4C). Remarkably, even the addition of large hydrophilic
ER membrane-impermeable probes [35], including PEG-5000
(Figure 1B, cf. lanes 9 and 10, *, and Figure 1D, lanes 7
and 8, ∞) and, for Sec61βOPG, PEG-20000 (Figure 1B, cf.
lanes 11 and 12), to the TA-regions did not prevent authentic
membraneinsertionoftherecombinantTAproteins.Perhapsmost
strikingly, a Cytb5OPG dimer modiﬁed with mPEG-5000 was
still capable of being efﬁciently inserted into the ER membrane
(Figure 1C, lane 2, and Figure 1D, cf. lanes 7 and 8,  ). It
is conceivable that the introduction of a PEG moiety into the
TA region of a protein might alter its choice of biosynthetic
route. In particular, we wished to conﬁrm that the requirements
for PEGylated Sec61βOPG were the same as those previously
deﬁned for the unmodiﬁed protein. Sec61β is known to exploit
the TRC40-dependent pathway for ER integration, a route that
is characterized by a protease-sensitive membrane component
[11,14]. We therefore investigated the effect of trypsin treatment
uponthemembraneintegrationofSec61βOPGandfoundthatthe
membrane association and N-glycosylation of both PEGylated
and non-PEGylated forms of the protein were identically
sensitive to protease treatment (see Supplementary Figure
S5A at http://www.BiochemJ.org/bj/436/bj4360719add.htm). In
contrast, the TRC40-independent membrane integration of Cytb5
was unaffected by trypsin treatment, conﬁrming both the
resilience of the N-glycosylation machinery and the speciﬁcity
of the assay (see Supplementary Figure S5A, and also [11,14]).
We also discovered that prequenching of mPEG-5000 maleimide
with glycine prevented the formation of aberrant products (cf.
Figure 1A, lane 5 and Supplementary Figure S5B), and used this
approach for all subsequent experiments.
PEGylation of Sec61βOPG affects distinct stages of its membrane
integration
Delivery of Sec61β to the ER membrane is mediated by the
TRC40protein[14],andifthiscytosolicfactorisremoved,theTA
protein fails to reach its target destination efﬁciently [10,28].
Several studies also suggest a role for yeast Sgt2p [18,26], and
its mammalian equivalent SGTA [28,36], acting on the same
pathway but upstream of Get3/TRC40 [17,20]. To address the
potential role of mammalian SGTA in TA protein biogenesis, we
analysed the interaction of our recombinant TRC40 substrate,
Sec61βOPG, with immobilized recombinant SGTA. We ﬁnd
that Sec61βOPG binds efﬁciently to SGTA, but not to a BSA
control, in a Triton X-100-sensitive manner (Figure 2A, lanes
2 and 3). PEGylated Sec61βOPG appears to bind at least as
efﬁciently as the unmodiﬁed protein (Figure 2A, lanes 2 and
3), and is also released by Triton X-100, consistent with a
hydrophobic interaction via the TA region as previously observed
for TRC40 binding (cf. [13]). In contrast, an alternative version
of Sec61β that lacks the hydrophobic TA region but also bears
a single PEG residue shows no association with immobilized
c   The Authors Journal compilation c   2011 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Constraints of tail-anchored protein biogenesis 723
Figure 2 Recombinant Sec61βOPG binds to immobilized SGTA
Sec61βOPGS77C (A)orSec61βOPG-TA110C eq. (seeSupplementaryTableS1)(B)werePEGylated
as described in the Experimental section and mixed with immobilized recombinant SGTA or a
BSA control. The Triton X-100 (TX)-or Laemmli buffer (SDS)-eluted fractions were resolved by
SDS/PAGE,andSec61βOPGvariantswerethendetectedbyimmunoblotting.Eachpanelshows
samples resolved on a single blot and exposed for the same time with irrelevant lanes removed.
An uncharacterized, but PEGylation-dependent, product of Sec61βOPG-TA110C eq. is indicated
(Y). Molecular-mass markers in kDa are also indicated on the right-hand side of the Western
blots.
SGTA, conﬁrming that the association of a PEG moiety alone is
notcapableofmediatingaTriton-sensitiveinteractionwithSGTA
(Figure 2B, lanes 2 and 3).
Crystal structures of Get3 [21,23,24], the yeast homologue of
TRC40, reveal that it has a deep groove at the dimer interface
that most likely acts as a TA protein recognition site. On the
basis of our results (cf. Figure 1B), similar to SGTA, TRC40
must presumably accommodate a Sec61β polypeptide modiﬁed
with a single mPEG-5000 moiety. To investigate further the
apparent ﬂexibility of substrate binding by TRC40, we mutated
both Ser
77 and Leu
79 of the Sec61βOPG TA-region into cysteine
residues(Sec61βOPG
S77C,L79C)andmodiﬁedthispolypeptidewith
mPEG-5000. Assuming that the transmembrane region adopts an
α-helix-likeconformation,thisdoublemodiﬁcationwouldyielda
TA protein with two PEG-5000 molecules extending from oppos-
ite sides of the polypeptide chain (Figure 3A). Immunoblotting
analysis conﬁrmed the efﬁcient labelling of Sec61βOPG
S77C,L79C,
yielding populations bearing both one and two mPEG-5000
molecules (Figure 3B, cf. lanes 1 and 2). When membrane
insertionwastested,bothunmodiﬁedandsinglyPEGylatedforms
of Sec61βOPG
S77C,L79C were visibly N-glycosylated, in agreement
with our previous results (Figure 3C, cf. lanes 3 and 4; cf.
Figure 1B, lanes 1 and 2, 9 and 10). However, no N-glycosylation
of Sec61βOPG
S77C,L79C labelled with two mPEG-5000 molecules
was seen, even after prolonged exposure of the immunoblot
(Figure 3C, cf. lanes 3 and 4; and results not shown).
The lack of any membrane-inserted Sec61βOPG
S77C,L79C that
had been modiﬁed with two PEG-5000 species could result
from either its inefﬁcient delivery to the ER membrane or
an inability to be integrated into the phospholipid bilayer.
To address this issue, we tested the association of the PEG-
labelled Sec61βOPG
S77C,L79C with TRC40 by immunoisolation
and quantitative immunoblotting. We found that the addition
of two PEG probes to a single TMS of Sec61βOPG
S77C,L79C
almost completely abolished TA protein binding to TRC40
(Figure3D,cf.lanes3and4,seealsoSupplementaryFigureS1at
http://www.BiochemJ.org/bj/436/bj4360719add.htm). Also, we
revealed that the attachment of even a single PEG probe
to Sec61βOPG
S77C,L79C reduced its binding to TRC40 to
approximatelyhalfthelevelobservedwiththeunmodiﬁedprotein
Figure 3 PEGylation of Sec61βOPGS77C,L79C prevents TRC40 binding
Sec61βOPGS77C,L79C was generated (see Supplementary Table S1 at http://www.BiochemJ.org/
bj/436/bj4360719add.htm)andthepuriﬁedproteinwasmodiﬁedwithmPEG-5000.Aschematic
diagramofthedoublylabelledpolypeptideispresentedassuminganα-helix-likeconformation
of the transmembrane region (A). Covalent attachment of PEG-5000 was conﬁrmed by
immunoblotting (B) and membrane integration by EndoH sensitivity (C). Small amounts
of Sec61βOPG species most likely corresponding to a dimer formed during protein
puriﬁcation were observed (B, ). Binding of PEG-modiﬁed Sec61βOPGS77C,L79C to TRC40
was addressed by pre-incubating the protein with rabbit reticulocyte lysate followed by
co-immunoprecipitation with anti-TRC40 or control anti-PDI antibodies. Bound Sec61βOPG
was eluted and detected by quantitative immunoblotting (D), allowing relative binding to
TRC40 to be compared (E, see Supplementary Figure S1 at http://www.BiochemJ.org/
bj/436/bj4360719add.htm for a full worked example). The values shown are the average from
two independent experiments. * indicates N-glycosylated species. Molecular-mass markers in
kDa are also indicated on the right-hand side of the Western blots.
(Figure 3E). This is consistent with a qualitative reduction
in the membrane integration of the singly modiﬁed chain
when compared with the unmodiﬁed version of Sec61βOPG
(Figure 3C, cf. lanes 3 and 4, marked 0×PEG and 1×PEG).
We next established whether a protein with a TA region
modiﬁed with two PEG-5000 molecules predicted to be located
o nt h es a m es i d eo fa nα-helix-like conformation can be
bound by TRC40 and delivered to the ER membrane. To
this end, a third derivative of Sec61βOPG with both Ser
77
and Val
84 mutated to cysteine residues (Sec61βOPG
S77C,V84C)
(Figure 4A) was puriﬁed and modiﬁed with mPEG-5000
(Figure 4B, cf. lanes 1 and 2). When the membrane integration
of the two double cysteine residue variants of Sec61βOPG
was compared, surprisingly little if any N-glycosylation of
even singly PEGylated Sec61βOPG
S77C,V84C could be detected
under conditions where the singly modiﬁed Sec61βOPG
S77C,L79C
was reproducibly integrated (Figure 4C). When the binding of
Sec61βOPG
S77C,V84C toTRC40wasanalysed,theinteractionofthe
singly PEGylated-Sec61βOPG
S77C,V84C species was unperturbed,
although association of the doubly PEGylated species was clearly
diminished(Figures4Dand4E).Hence,althoughTRC40binding
is relatively tolerant of the addition of a single PEG-5000 moiety
to the Sec61β TA-region, a subsequent step of the membrane
insertion process appears much more sensitive to the precise
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Figure 4 PEGylation of Sec61βOPGS77C,V84C inhibits membrane integartion
(A) Puriﬁed recombinant Sec61βOPGS77C,V84C (see Supplementary Table S1 at http://www.
BiochemJ.org/bj/436/bj4360719add.htm) was modiﬁed with mPEG-5000 and is shown
schematicallyasdescribedforFigure3(A).(B–D)PEGylationwasconﬁrmedbyimmunoblotting
(B) with a presumptive Sec61βOPG dimer indicated (). Membrane integration was
determined by EndoH sensitivity (C), and TRC40 binding (D and E) was analysed as
detailed in the legend to Figure 3 (see also Supplementary Figure S1 at http://www.
BiochemJ.org/bj/436/bj4360719add.htm).*indicatesN-glycosylatedspecies.Molecular-mass
markers in kDa are also indicated on the right-hand side of the Western blots.
location of such a probe and PEGylation of Cys
84 appears not
to be tolerated.
In order to test this hypothesis further, we generated a
single cysteine residue mutant, Sec61βOPG
V84C, and studied
its membrane integration compared with the Sec61βOPG
S77C
mutant. Cys
84 was more efﬁciently PEGylated than Cys
77
(Figure 5A and Supplementary Figure S1A), but the resulting
Sec61β derivative showed little if any membrane-dependent
N-glycosylation, whereas Sec61βOPG
S77C was again efﬁciently
modiﬁed (Figure 5A, lanes 3 to 6), as previously observed
(Figure1B,lanes9and10).Furthermore,theeffectofPEGylation
of residue 84 could not be correlated to a reduction in TRC40
binding (Supplementary Figure S1). Hence the PEGylation of a
single cysteine residue located at amino acid 84 of Sec61βOPG
effectively prevents membrane integration as judged by
N-glycosylation. One potential explanation for this location-
speciﬁc effect of PEGylation is the thermodynamic cost of
integratingthemodiﬁedTAregionintoaphospholipidbilayer(see
alsoFigure6B,theSupplementaryonlinedataandSupplementary
Table S2 at http://www.BiochemJ.org/bj/436/bj4360719add.htm
and the Discussion section). We therefore explored the
consistency of this positional effect by analysing the membrane
integration of PEGylated forms of three further single cysteine
residue mutants, L74C, L87C and a novel cysteine residue,
added to the C-terminus of Sec61βOPG, denoted 110C.
We observe that the membrane integration of PEGylated
Sec61βOPG
L74C and Sec61βOPG
S77C is clearly more efﬁcient
than that of PEGylated Sec61βOPG
V84C, Sec61βOPG
L87C and
Sec61βOPG
110C (Figures 5A, 5B and 5C). To conﬁrm that the
location-speciﬁc effect of PEGylation was due to a perturbation
of membrane integration, and not N-glycosylation itself, we
also carried out a protease protection analysis (cf. [10]). We
couldidentifyadiscretemembrane-dependentprotease-protected
fragment of PEGylated Sec61βOPG
S77C (Figure 5D, lane 5,
ﬁlled triangle). In contrast, no such product was observed with
Sec61βOPG
V84C or Sec61βOPG
110C (Figure 5D, lane 8 and
Figure 5E, lane 2, predicted location indicated by ). On this
basis, we conclude that the PEGylation of amino acid residues
located towards the C-terminus of Sec61βOPG preferentially
inhibits membrane integration.
DISCUSSION
We have exploited recombinant TA proteins as a tool for better
understanding their biogenesis at the ER. Both Sec61βOPG
[28] and Cytb5OPG (the present study) are efﬁciently integrated
into ER-derived membranes, and in both cases this process
is dependent upon the presence of cytosol. The role of
cytosolic factors in the membrane integration of Cytb5 remains
controversial [7,8,10]. Nevertheless, in the present study we can
only detect an N-glycosylated membrane integrated form of the
protein in the presence of lysate (cf. [7]). In the case of Sec61β,
the requirement for cytosol correlates to a need for TRC40/Asna-
1 [13,14], and other cytosolic factors including Bat3 [28] and the
mammalian homologues of Get4 and Get5 [37]. We now provide
the ﬁrst evidence for a direct interaction between Sec61β and
SGTA,themammalianequivalentofyeastSgt2.Sgt2hasrecently
been implicated in the transfer of TA protein substrates to Get3
[20]. These studies support our previous observation of a speciﬁc
association between SGTA and TA regions [28], and we now
conclude that this represents a direct interaction of SGTA with
a hydrophobic substrate [38], and speculate that SGTA normally
plays a role in TA protein transfer to TRC40.
Sec61β can tolerate the covalent attachment of a variety of
reagents to a single cysteine residue located within its TA region,
and retain its ability to be integrated into the ER membrane.
Likewise, the membrane integration of Cytb5 is not blocked
by the addition of a PEG-5000 moiety close to the middle of
its TA region or by the formation of a protein dimer. In the
case of Sec61β, polypeptides with various attachments including
PEG-5000, and even PEG-20000, can all be post-translationally
integrated.Thissuggeststhatthecellularcomponentsthatmediate
its delivery to, and integration into, the ER membrane can
accommodatearangeofnon-physiologicalmodiﬁcationswithout
a substantial perturbation of their function. Our analysis of the
binding of Sec61βOPG to cytosolic factors implicated in its
delivery to the ER showed that the direct binding of recombinant
Sec61βOPG
S77C to SGTA was unaffected by PEGylation. Since
the PEG moiety is attached to the hydrophobic TA region,
this would suggest that SGTA has a hydrophobic groove-like
binding site capable of accommodating this unnatural substrate.
Interestingly, both TRC40 and the 54 kDa subunit of the SRP
each have ﬂexible hydrophobic clefts capable of accommodating
a range of hydrophobic polypeptide regions [21,23,39], further
supporting this notion (see also [20]).
To analyse the effects of PEGylation upon TRC40 binding,
we engineered double cysteine residue mutants of Sec61βOPG
that generated a mixture of singly and doubly modiﬁed species
upon PEGylation and determined their association by co-
immunoprecipitation. This analysis showed that the singly
PEGylated form of Sec61βOPG
S77C,L79C can still bind to TRC40
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Figure 5 Distinct effects of PEGylation at different locations within the Sec61β TA-region
Additional single cysteine Sec61βOPG variants were generated (see Supplementary Table S1 at http://www.BiochemJ.org/bj/436/bj4360719add.htm) and PEGylated. The membrane integration of
PEGylated Sec61βOPGS77C and Sec61βOPGV84C (A), Sec61βOPGL74C and Sec61βOPGL87C (B) and Sec61βOPGS77C and Sec61βOPG110C (C) were determined by EndoH sensitivity. In addition,
the membrane integration status of Sec61βOPGS77C and Sec61βOPGV84C (D) and Sec61βOPG110C (E) was determined by protease protection (see the Experimental section). The ﬁlled triangle
indicates the actual (D, lane 5) or predicted (D, lane 8 and E, lane 2) location of a protease protected, PEGylated, fragment of Sec61βOPG. In (C), the Sec61βOPG110C samples were overexposed in
ordertobestvisualizeanyN-glycosylatedPEGylatedproducts.*indicatesN-glycosylatedspecies;indicatespredictedlocationofmembrane-dependentprotease-protectedfragmentofPEGylated
Sec61βOPG. Molecular-mass markers in kDa are also indicated on the right-hand side of the Western blots. PK, proteinase K; TX, Triton X-100.
with substantial efﬁciency, whereas a doubly modiﬁed form
cannot. When this PEGylated TA region is modelled into the
substrate-binding site of TRC40, our data are in good agreement
with the proposed deep pocket [21–24] that could accommodate
the addition of one centrally localized PEG-5000 to the substrate,
but not two (see Figure 6A). Hence, we conclude that the
doubly PEGylated form of Sec61βOPG
S77C,L79C is incapable of
membrane integration due to its inability to bind TRC40. When
an alternative cysteine residue mutation was used to generate
a doubly PEGylated variant, Sec61βOPG
S77C,V84C, although the
singly modiﬁed protein could bind TRC40, it was no longer
membrane-integrated. Subsequent analysis of the single cysteine
residue mutant Sec61βOPG
V84C showed that PEGylation of
Cys
84 speciﬁcally perturbs biosynthesis at a step occurring after
TRC40 binding; for example, substrate release by TRC40 or
the subsequent membrane integration step (Figure 6C). Our
calculationsofthefreeenergychangesresultingfromtheinsertion
of a PEG polymer into a lipid bilayer favour the introduction of
aconstraintatthemembraneinsertionstep.Hence,thefreeenergy
associated with the transfer of the unmodiﬁed Sec61βOPG TMS
into a lipid bilayer can be estimated as −11.5 kcal (1 kcal=
4.184kJ)/mol(seeSupplementaryonlinedataandSupplementary
Table S2), assuming a non-Sec61 translocon-mediated pathway
for insertion [7,40,41]. By the same criteria, the integration of
Sec61βOPGPEGylatedatCys
77 hasanestimatedenergeticcostof
−4kcal/mol,andhenceremainsfavourable(Figure6B,S77C).In
contrast, the energetic cost of integrating Sec61βOPG PEGylated
at Cys
84 is +1 kcal/mol (Figure 6B, V84C; see Supplementary
onlinedatafordetailedcalculations).Thusourmodellingsupports
the idea that the membrane integration efﬁciency of a PEGylated
Sec61β TA region is dependent on the precise location of the
probe relative to the lipid bilayer (Figure 6B).
To further challenge this model, we created three further
single cysteine residue mutants of Sec61βOPG, Sec61βOPG
L74C,
Sec61βOPG
L87C and Sec61βOPG
110C and analysed the membrane
integration of their PEGylated species. As predicted, the modi-
ﬁcationofresidue74towardstheN-terminalsideoftheTAregion
did not prevent membrane integration, whereas the alteration of
residue 87 towards the C-terminal end, and the addition of a novel
cysteine at the extreme C-terminus, both did. Taken together,
these observations suggest that thermodynamic constraints are a
major factor in the membrane integration of TRC40-dependent
TA proteins. Although we cannot exclude the possibility that the
membrane insertion of Sec61β requires a specialized integrase,
webelievethatthedistinctbehaviourofthedifferentlyPEGylated
Sec61β TA regions is more consistent with a simple partitioning
model for membrane insertion. In this scenario, the recently
identiﬁed membrane-bound receptor for TRC40 [42] would act
to deliver TA proteins to the surface of the ER membrane,
but subsequent integration would rely solely on the favourable
thermodynamics of TA protein partitioning into the lipid bilayer
(Figure 6C, cf. [7]).
In the case of Cytb5, the precise identity of any cellular
components that mediate its membrane delivery and integration
are uncertain [10,13,14,28,29]. Nevertheless, we see an equally
ﬂexible pathway for Cytb5 biogenesis that can tolerate both
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Figure 6 Membrane delivery and integration of PEG-modiﬁed Sec61β
(A) Left-hand panel, human TRC40 was modelled using the S. cerevisiae Get3 dimer structure
as a template (PDB code2WOJ) and with the 23-amino-acid-residue α-helical TMS of Sec61β
(green)shownintheproposedbindinggroove.ThesurfaceoftheTRC40dimeriscolour-coded
byaminoacidpolarity:blue,positivelycharged;grey,non-polar;red,negativelycharged;yellow,
polar-uncharged.Right-handpanel,aschematicrepresentationfortheassociationofPEGylated
Sec61β with TRC40 showing binding of polypeptides PEGylated at residue 77 or 84, but not
of a doubly modiﬁed Sec61βS77C,L79C variant. (B) Left-hand panel, estimated energy changes
(seeSupplementaryonlinedataathttp://www.BiochemJ.org/bj/436/bj4360719add.htm)forthe
incorporationofdifferentsinglyPEG-modiﬁedTA-regionsofSec61βOPGintoalipidbilayer.The
relative G valuesforPEGylationatresidues74,77,84and87areindicated.Right-handpanel,
representation of PEGylated Sec61β TA regions within a model lipid bilayer using membrane
co-ordinates taken from [47]. Experiments conﬁrm the efﬁcient membrane integration of a
Sec61βOPGPEGylatedonCys74 andCys77,butnotCys84,Cys 87 orCys110.(C)Workingmodel
for the delivery of PEGylated Sec61β to the ER membrane. A variety of upstream components
including Bat3, SGTA and mammalian Get4 and Get5 [27,28,37] facilitate TRC40-mediated
delivery to the mammalian ER membrane via its receptor [42]. Any requirement for a membrane
integraseremainshypothetical(cf.[7]).CovalentmodiﬁcationoftheTAregionofSec61β could
in principle perturb any one of the steps illustrated.
PEGylation and enforced dimerization. We conclude that any
cytosolicfactorsthatfacilitateCytb5integrationcantoleratethese
species without substantial perturbation (Figure 1). Once at the
membrane, the rate at which Cytb5OPG can be N-glycosylated
appears to be substantially higher than that of Sec61βOPG
(Supplementary Figure S2), and Cytb5OPG integration is also
insensitivetotrypsintreatmentofthemembranes(Supplementary
Figure S5), further supporting the use of different pathways for
integration into the ER [7,33,34]. Whether the ﬂexibility of the
post-translational pathways that underlie TA protein biogenesis is
of physiological signiﬁcance remains to be determined. However,
ourresultsareingoodagreementwiththeﬁndingthatcertainviral
proteins are palmitoylated within their TMSs prior to membrane
integration [43]. They are also consistent with the proposal that
soluble SNAP-25 (25 kDa synaptosome-associated protein) is
initially targeted to the ER membrane in a complex with the TA
protein syntaxin [44], presumably via the binding of the complex
to TRC40 prior to ER delivery [14]. It may even be the case that
SGTA and TRC40 can bind to covalently modiﬁed TA proteins
thataregeneratedinvivosuchasubiquitinatedspecies,consistent
with reports of the co-translational ubiquitination of membrane
proteins [45] and known links between the yeast homologue of
TRC40, Get3 and the ubiquitin–proteasome system [46].
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A biochemical analysis of the constraints of tail-anchored protein
biogenesis
Pawel LEZNICKI, Jim WARWICKER and Stephen HIGH1
Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, U.K.
Calculations of the energetic cost for membrane integration of
PEGylated Sec61βOPG
Boundaries of the membrane-spanning region of Sec61βOPG
were determined using a prediction algorithm for changes in free
energy,  G, upon Sec61 translocon-mediated protein integration
into a lipid bilayer [1]. The transfer energy for the predicted
23-amino-acid segment (see Table S1) was calculated on the
basis of the water/octanol partition scale [2] and a value of
−11.5 kcal/mol was obtained.
logP values of atom fragments of the mPEG-5000 maleimide
moiety were computed by best ﬁt to a training set of 2473
compounds [3], and the sum obtained (−5.0 to −5.3) was in
good agreement with the data available for the logP of PEG-
400 derived from water/hexane partitioning (−4.824), assuming
thatPEG-400iscomposedof,onaverage,eightornineCH2CH2O
Figure S1 TRC40 binding to PEGylated Sec61βOPG
(A)PEGylatedSec61βOPGS77C orSec61βOPGV84C wereincubatedinthepresenceofrabbitreticulocytelysatefollowedbyco-immunoprecipitationwithanti-TRC40orcontrolanti-PDIantibodiesas
indicated. Bound Sec61βOPG variants were then eluted and detected by quantitative immunoblotting using a LiCor system (see the Experimental section of the main text) to estimate the association
of the unmodiﬁed and PEG-modiﬁed forms with TRC40. Molecular-mass markers are shown in kDa on the right-hand side. (B) The actual values obtained from the LiCor system for each of the
products analysed (see boxes in A) for two separate experiments are shown, together with the method for calculating Sec61βOPG binding. Non-speciﬁc binding to Protein A–Sepharose coated with
anti-PDI antibody was subtracted from the binding to anti-TRC40 antibody-coated Protein A–Sepharose, and the resulting values were normalized to the amount of each Sec61βOPG species. These
results are expressed graphically for Sec61βOPGS77C (C) and Sec61βOPGV84C (D).
repeats, and taking into account any potential discrepancy
between water/hexane and water/octanol systems. Making
equivalent calculations for a 35 Å (1 Å = 0.1 nm) stretch of PEG,
corresponding to the length of the predicted tail-anchor region,
and converting the results to  G, the cost of transferring the PEG
polymer into a lipid bilayer in a conformation that spans both
leaﬂets was estimated as approximately +3.6 kcal/mol.
A rotameric entropy loss for an extended PEG chain was
estimated on the basis of a comparison with studies of aliphatic
side chain conformers in proteins [4] and the role of ligand
rigidiﬁcation in modulating binding afﬁnities [5]. Hence, the
entropy was calculated from the equation S =− R (P ln P),
where R is the universal gas constant, P the probability for each
rotamer, and the sum is taken over all rotamers. For a torsional
system with three stable rotamers, assuming a transition between
equalprobabilitiesforeach,andjustone(extendedchain)rotamer,
1 To whom correspondence should be addressed (email stephen.high@manchester.ac.uk).
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afreeenergycontributionof +0.6kcal/molatT =300Kforeach
torsion was obtained. Over the 35 Å TMS length, this amounts to
+17.0 kcal/mol for a fully extended chain.
A contribution of the mPEG-5000 maleimide linker region
to the energetic cost of inserting PEGylated Sec61βOPG into
a lipid bilayer was estimated making an assumption, on the basis
of the manufacturer’s data, that in the experimental conditions
usedthemaleimide-linkerringremainsintact.Takingintoaccount
the nature of the maleimide-linker components and their bond
rotamer status, the following parameters were calculated: length
in the extended conformation, 10 Å;  G for octanol partitioning
of −0.5 kcal/mol (calculated from logP); rotamer entropy loss
in extended conformation contributing +3.6 kcal/mol, i.e. a net
value of +3.1 kcal/mol.
The estimated contribution of each component to the overall
energetic cost for the membrane integration of the PEGylated
forms of Sec61β
L74C, Sec61β
S77C, Sec61β
V84C and Sec61β
L87C is
presentedinTableS2.Althoughthe Gvaluesshownforthelipid
partitioning of PEG attached to these distinct sites are estimates
and absolute values may differ, our calculations clearly indicate
that the integration of PEGylated Sec61β is ﬁnely balanced,
such that it changes from favourable to unfavourable as the site
of PEG modiﬁcation is moved deeper into the membrane from
the cytosolic face. It should be noted that, in all calculations
presented above, an extended conformation of the maleimide–
PEG moiety, parallel to the TA of Sec61β, was assumed.
This conformation minimizes occlusion of the PEG chain from
the solvent and provides a deﬁned conformer for calculations.
Although other conformations are theoretically possible, these
would most likely require higher energy for their membrane
integration, due to the increased number of the PEG repeats that
wouldhavetobeaccommodatedbythelipidbilayer.Inaddition,it
is assumed that the bulk of the PEG molecule does not translocate
across the membrane, consistent with experimental data, so that
PEG traversal of the membrane is always modelled from the
cysteine/maleimide linker to the cytosolic side.
Figure S2 Characterization of recombinant Sec61βOPG and Cytb5OPG
(A) Coomassie Blue-stained gel of puriﬁed recombinant Sec61βOPGS77C and Cytb5OPGS119C
both prepared using buffers supplemented with 0.75% (w/v) octyl-β-D-glucopyranoside
(see also [6]). (B) Membrane integration reactions of recombinant Sec61βOPGS77C and
Cytb5OPGS119C carried out in the presence of reticulocyte lysate (see [6]), and using
immunoblotting for detection and EndoH sensitivity of N-glycosylated products (*) to conﬁrm
membrane integration. (C and D) Time course for the membrane integration (integr.) of
Sec61βOPGS77C (C)andCytb5OPGS119C (D)performedasdescribedfor(B).Truncatedversions
of Cytb5OPG (); Sec61βOPG () and N-glycosylated Sec61βOPG () are indicated.
Molecular-mass markers in kDa are also indicated.
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Figure S3 BODIPY
® labelling of Sec61βOPG
PuriﬁedrecombinantSec61βOPGS77C wasmodiﬁedwithBODIPY® maleimideornot(unmodif.)
as indicated, and membrane integration (integr.) was analysed as described in the text (see
also Figures 1A and 1B of the main text). Fluorescently labelled products recovered with
the membrane fraction were visualized directly using a FUJIFILM LAS-3000. N-glycosylated
products are indicated (*). Molecular-mass markers in kDa are also indicated on the right-hand
side.
Figure S4 Both monomers of TA protein dimers are authentically integrated into the ER membrane
(A) Dimers of Sec61βOPG were generated by cross-linking the single cysteine mutant S77C (see Supplementary Table S1) with 1 mM of the indicated thiol-reactive reagents with a spacer length
of 8–13 A ˚. The reaction mixtures were incubated for 10min at 25◦C, quenched with 15 mM 2-mercaptoethanol and the modiﬁed proteins were used in a membrane integration assay (see [6]).
The membrane-associated fraction was isolated by centrifugation, treated with Endo H where indicated and products were analysed by immunoblotting. N-glycosylated monomers and dimers are
indicated(1xglyc.and2xglyc.respectively).BMB,1,4-bis(maleimido)butane;BMOE,bis(maleimido)ethane.(BandC)BMHcross-linkedsinglecysteinemutantsofSec61βOPG(B)andCytb5OPG
(C)wereusedinamembraneintegrationreaction[6],andtheisolatedmembranefractionsubjectedtopartialdigestionwithEndoH(0.21units/μl).Attheindicatedtimes,aliquotsweremixeddirectly
with Laemmli sample buffer, and products were subsequently analysed by immunoblotting. Migration of Sec61βOPG and Cytb5OPG dimers is indicated, and various N-glycosylated (glycosyl.)
speciesofbothproteinsareshown(*).ThedoubletcorrespondingtotheSec61βOPGdimerresultsfromatruncatedformoftherecombinantprotein(seeFigureS2),leadingtoapopulationofmixed
dimers. These species are also responsible for the additional N-glycosylated protein species identiﬁed by EndoH treatment (B). Molecular-mass markers in kDa are indicated on the right-hand side.
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Table S1 Sequence of TA proteins used in the present study
Sequences of TA proteins used in the present study are shown, with the predicted transmembrane segments in bold and the opsin-derived, C-terminal tag underlined. Mutations introduced into the
amino acid sequences are indicated by asterisks (*). Amino acid numbering reﬂects that of the wild-type proteins; however, the recombinant versions lack an initiator methonine residue and have
instead a GlySer dipeptide (italics) resulting from the thrombin-mediated cleavage of the N-terminal HisTrx tag.
Protein (species) Sequence
Sec61βOPGS77C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMC*LLFIASVFMLHIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPGV84C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMSLLFIASC*FMLHIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPGL74C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVC*VMSLLFIASVFMLHIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPGL87C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMSLLFIASVFMC*HIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPGS77C,L79C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMC*LC*FIASVFMLHIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPGS77C,V84C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMC*LLFIASC*FMLHIWGKY-
TRSGPNFYVPFSNKTG
Sec61βOPG110C (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPVPVLVMSLLFIASVFMLHIWGKY-
TRSGPNFYVPFSNKTGC*
Sec61βOPG-TA110C eq. (human) GSPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASS*GTRSAGRTTSAGTGGMWRFYTEDSPGLKVGPGPNFYVPFSNKTGC*
Cytb5OPGS119C (human) GSAEQSDEAVKYYTLEEIQKHNHSKSTWLILHHKVYDLTKFLEEHPGGEEVLREQAGGDATENFEDVGHSTDAREMSKTFIIGELHPDDRPKLNKPPETLITT-
IDSSSSWWTNWVIPAIC*AVAVALMYRLYMAEDGPNFYVPFSNKTG
Figure S5 Characterization of PEGylated Sec61βOPG
(A) PEGylated Sec61βOPGS77C or unmodiﬁed (unmodif) Cytb5OPGS119C were incubated in the
presence of reticulocyte lysate and sheep microsomes that had been pretreated with increasing
amountsoftrypsin(tryp.)asindicated.Themembranefractionwasrecoveredandproductswere
visualizedviaimmunoblottingoftheC-terminalopsintag.N-glycosylatedproductsareindicated
(*).(B)WesternblotshowingpuriﬁedSec61βOPGvariantsthatwereuntreated(lane1),treated
with mPEG-5000 prequenched with glycine (lanes 2 and 4) or treated with mPEG-5000 without
prequenching(lane3).PEGylatedformsareindicatedtogetherwithadistinctunassignedproduct
seen only in the absence of glycine prequenching (?). S77C, Sec61βOPGS77C; S77C/L79C,
Sec61βOPGS77C,L79C. Molecular-mass markers in kDa are indicated on the right-hand side.
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TableS2 Contributionofdifferentfactorstotheenergeticcostofmembrane
integration of the PEGylated variants of Sec61β
See the text for more details. All values are in kcal/mol unless stated otherwise.
Tail-anchor Maleimide PEG PEG
PEG link contribution linker distance (A ˚) contribution Sum
L74C −11.5 3.1 3.9 2.3 −6.1
S77C −11.5 3.1 7.5 4.4 −4.0
V84C −11.5 3.1 16 9.4 1.0
L87C −11.5 3.1 19.6 11.5 3.1
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